RECORDING AVAILABLE: ADAI Lunch & Learn: Of Mice and Misuse: Preclinical Modeling of Fentanyl Use Disorder
01/30/2026
This session was hosted in January 2026. Find the recording here!
Kevin Coffey, PhD, is a Research Assistant Professor in UW Psychiatry and Behavioral Sciences and a MIRECC Investigator at the VA Puget Sound. His lab aims to identify the neural mechanisms underlying substance use disorders and maladaptive decision making.
Dr. Coffey’s current focus is on studying the neurobiological consequences and predictors of chronic fentanyl use. To accomplish this, his lab utilizes cutting-edge in-vivo optical neuroscience tools (photometry, optogenetics, MiniScopes, etc.) along with a newly developed oral fentanyl self-administration model for rats and mice.
In this session, Dr. Coffey discussed his recently funded ADAI pilot grant, which aims to explore the use of the GLP-1R agonist dulaglutide for treatment of fentanyl use disorder in his rodent models.
